| Charles R. Denham, MD
Dr. Denham has had a healthcare product and solution development career that has spanned over 20 years. He was an Associate Professor of Biomedical Engineering at the University of Texas in Austin from 1983 to 2003 and he has also served as an instructor at a number of medical schools and business schools - with a focus on innovation adoption, technology transfer, and commercialization.
His research has resulted in numerous product and process innovations in surgery, oncology, imaging, image guided surgery, pharmaceuticals and ophthalmology. He has served on the editorial boards of journals as a technology application specialist and authored several works in basic science, managed care and medication management and safety. He is Editor-and-Chief of the Journal
of Patient Safety. He was a fellow of the Harvard University Advanced Leadership Initiative in 2009 and was a senior fellow of the same program for 2010 and 2011. He has been an instructor at the Harvard School of Public Health and is an adjunct Professor of Healthcare Services Engineering at the Mayo Clinic College of Medicine. He is a member of the President's Circle of the National Academies of Science advising the Institute of Medicine, National Academy of Science, and National Academy of Engineering. He is a Global Fellow of the Institute for Innovation, Creativity, and Capital (IC 2 ) at the University of Texas at Austin. He is a co-founder of the Global Patient Safety Forum in Geneva Switzerland, a convener of global healthcare leaders in high performance accountable healthcare and is a collaborator with the World Health Organization.
He is CEO of the HCC Corporation (HCC). Launched in 1983, HCC is a business development accelerator in medical, technical, and service product fields. It has led, developed, or supported over 400 product development teams in over 50 product categories including pharmaceuticals, devices, capital equipment, and software applications. Non-medical HCC efforts range from aerospace, e-commerce, fitness, and software to consumer health product categories. HCC is the developer of a care-centered, evidence-based Breakthrough Technology Processing System now used for product assessment and purchase by one third of US hospitals purchasing over $25 billion in products in 2009. Dr. Denham is the inventor of software-based innovation design and development decision support systems, which HCC has further developed, that is used by numerous global healthcare supplier and high technology companies with more than $90 billion in revenues and over 95% U.S. hospital market penetration. HCC is a private equity investor in high impact evidence based products, services, and technologies. It provides the infrastructure for accelerated market penetration.
Dr. Denham is a founder and Chairman of the Texas Medical Institute of Technology (TMIT), a non-profit medical research organization dedicated to drive adoption of clinical solutions in patient safety and healthcare performance improvement. TMIT and HCC have established a National Research Test Bed of more than 3100 hospitals through which it studies and accelerates the adoption of high impact performance improvement solutions consisting of products, services, and technologies that enable best practices. The numerous task forces and practicing communities of TMIT are served by an online knowledge management system which can be accessed at www.SafetyLeaders.org
TMIT sponsors numerous projects in patient safety and collaborates with the Institute for Healthcare Improvement for which Dr. Denham serves as a faculty member in the area of technology assessment and adoption. TMIT is a leading developer of practical practices that enable providers to succeed in national and local Pay-For-Performance programs. TMIT and HCC have had formal collaborative initiatives with numerous federal agencies and associated organizations including the Centers for Medicare and Medicaid (CMS), the Institute of Medicine (IOM), Health Resources and Services Administration (HRSA), the Agency for Healthcare Research and Quality (AHRQ), NASA, and the Department of Defense (DOD). Dr. Denham was a member of the leadership alliance of the Secretary of Health and provided advisory support to the national organ donor initiative sponsored by HRSA.
Since 2003, Dr. Denham has been the Chairman of The Leapfrog Group Safe Practices Program. The Leapfrog Group is a consortium of more than 185 Fortune 500 companies with over $69 billion in healthcare purchasing power who are responsible for more than 34 million covered lives. The TMIT funded program ranks US hospitals on an annual basis, providing the mechanism for consumers and insurance purchasers to reward quality improvement and patient safety by their purchasing. The initiative, chaired by Dr. Denham, is served by a Senior Medical Advisory Board including ten global leaders in patient safety and quality and more than 250 clinical and administrative subject matter experts from a number of our nation's best academic and frontline institutions. The program focuses on 34 Safe Practices established by a public-private partnership, led by the National Quality Forum (NQF), charged by the US Congress to establish standards under the auspices of the Innovation Transfer Act of 1995. TMIT has funded and leads this multi-year program with yearly updates to a survey, scoring method, and national ranking system. TMIT is the producer of Chasing Zero: Winning the War on Healthcare Harm, a documentary released by the Discovery Channel in April 2010. Dr. Denham is the executive producer of the film. He wrote, directed, and produced a second documentary: Surfing the Healthcare Tsunami: Bring Your Best Board also released by Discovery Channel in 2012.
In 2005, Dr. Denham was appointed Co-chairman of the NQF Safe Practices Consensus Standards Maintenance Committee, which is responsible for updating the NQF Safe Practices on an ongoing multi-year basis. TMIT has established an individual TMIT task force with each of JCAHO, CMS, AHRQ, IHI, and the Leapfrog Group in order to generate a synchronized set of practices that will provide a common roadmap to hospitals. This harmonization initiative provides a common set of targets that the payers can build into their purchasing methods. TMIT has also funded a national Healthcare Associated Infection project in collaboration with NQF which will establish consensus standards for hospital reporting in late 2007.
In 2006 Dr. Denham was ranked 31 of the 50 Most Powerful Physician Executives by Modern Healthcare and in 2012 was ranked 38.
He has also served in various roles with the World Health Organization.
Dr. Denham has been the co-chair the 2010 NQF Safe Practices update and implementation by the Leapfrog Group. He also co-chaired NQF consensus committee for Laboratory in 2009.